TLX — Telix Pharmaceuticals Ltd
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2007191 ·
Last close
$8.85
Market Cap
$3.01B
52W High
$13.11
52W Low
$6.28
ADV30
336,690
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 1,361,851,000 | 251,910,000 | 874,176,000 |
| Dec 2025 | — | — | — | — | 1,163,986,000 | 141,866,000 | 748,610,000 |
| Jun 2025 | — | — | — | — | 1,189,952,000 | 207,156,000 | 768,011,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-110,896,000
Inventory
$39,029,000
Receivables
$170,388,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$890,785,024
EBITDA
$69,806,000
Free Cash Flow
$-62,596,000
Enterprise Value
$4,164,115,712
Total Cash
$251,910,000
Total Debt
$579,860,992
Shares Out
339,784,294
Trailing EPS
$0.10
Book Value
$1.44
ROE
7.4%
ROA
2.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 803,794,000 | 18,053,000 | -7,125,000 | 1,163,986,000 | 748,610,000 | 415,376,000 | — |
| Dec 2024 | 516,551,000 | 55,584,000 | 33,685,000 | 940,379,000 | 587,442,000 | 352,937,000 | — |
| Dec 2023 | 332,978,000 | 34,965,000 | 4,208,000 | 277,258,000 | 174,613,000 | 102,645,000 | — |
| Dec 2022 | 108,913,289 | -50,475,530 | -70,804,931 | 173,716,614 | 119,287,862 | 54,428,752 | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.15
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | $3.00B | $16.02 | — |
| XERS | Xeris Biopharma Holdings, Inc. | $3.07B | $16.80 | — |
| BGM | BGM Group Ltd. | $3.09B | $8.13 | — |
| ZLAB | Zai Lab Ltd | $2.91B | $23.53 | — |
| LEGN | Legend Biotech Corp | $3.13B | $16.11 | — |
News headlines (Yahoo Finance, 1h cache)
Telix to Participate in UBS Global Biopharma Conference
2026-11-11 07:00 · Yahoo
Telix Joins Thera4Care with TLX400-Tx to Accelerate Translation of Next Generation FAP-Targeting Theranostics
2026-11-05 05:30 · Yahoo
Telix Pharmaceuticals Targets $1.5B Revenue as ITM Deal Speeds Therapy Push
2026-11-04 08:14 · Yahoo
Telix Reports Third Quarter 2026 Financial Performance
2026-10-20 22:10 · Yahoo
Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.
2026-10-19 05:30 · Yahoo
Profound Medical Corp (PROF) (Q3 2026) Earnings Call Highlights: Revenue Surges 86% as Pipeline ...
2026-11-06 05:26 · Yahoo
Talanx Q3 Earnings Call Highlights
2026-11-12 11:13 · Yahoo
3 Australian Growth Stocks With Revenue Growth Up To 52%
2026-11-07 13:11 · Yahoo
Regis Healthcare And 2 Other Australian Insider Owned Growth Stocks
2026-11-04 05:14 · Yahoo
3 Australian Growth Stocks With Revenue Growth Up To 17%
2026-11-03 04:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.